Literature DB >> 3627214

Proto-oncogenes and human cancers.

D J Slamon.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3627214     DOI： 10.1056/NEJM198710083171509

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  26 in total

1.  Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.

Authors:  Brooke M Emerling; Jonathan B Hurov; George Poulogiannis; Kazumi S Tsukazawa; Rayman Choo-Wing; Gerburg M Wulf; Eric L Bell; Hye-Seok Shim; Katja A Lamia; Lucia E Rameh; Gary Bellinger; Atsuo T Sasaki; John M Asara; Xin Yuan; Andrea Bullock; Gina M Denicola; Jiaxi Song; Victoria Brown; Sabina Signoretti; Lewis C Cantley
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

Review 2.  Recombinant DNA and surgery.

Authors:  J M Brown; A H Harken; J B Sharefkin
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

3.  Dimerization in the Grb7 protein.

Authors:  Tabitha A Peterson; Renee L Benallie; Andrew M Bradford; Sally C Pias; Jaron Yazzie; Siamee N Lor; Zachary M Haulsee; Chad K Park; Dennis L Johnson; Larry R Rohrschneider; Anne Spuches; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2012-08       Impact factor: 2.137

4.  Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients.

Authors:  Claudia Omarini; Stefania Bettelli; Cecilia Caprera; Samantha Manfredini; Federica Caggia; Giorgia Guaitoli; Luca Moscetti; Angela Toss; Laura Cortesi; Shaniko Kaleci; Antonino Maiorana; Stefano Cascinu; Pier Franco Conte; Federico Piacentini
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

5.  Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer.

Authors:  Shanthi Kanthala; Sashikanth Banappagari; Ameya Gokhale; Yong-Yu Liu; Gu Xin; Yunfeng Zhao; Seetharama Jois
Journal:  Chem Biol Drug Des       Date:  2014-11-06       Impact factor: 2.817

Review 6.  Molecular biology of testicular germ cell tumors: current status.

Authors:  B Schmidt; R Ackermann; T Strohmeyer
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

7.  Invasive Breast Cancer: Recognition of Molecular Subtypes.

Authors:  Johanna D Strehl; David L Wachter; Peter A Fasching; Matthias W Beckmann; Arndt Hartmann
Journal:  Breast Care (Basel)       Date:  2011-08-26       Impact factor: 2.860

8.  Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.

Authors:  Samir Koirala; Lynn N Thomas; Catherine K L Too
Journal:  Mol Endocrinol       Date:  2014-01-16

9.  The cell migration protein Grb7 associates with transcriptional regulator FHL2 in a Grb7 phosphorylation-dependent manner.

Authors:  Sharareh Siamakpour-Reihani; Haroula J Argiros; Lori J Wilmeth; L Lowell Haas; Tabitha A Peterson; Dennis L Johnson; Charles Brad Shuster; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2009 Jan-Feb       Impact factor: 2.137

10.  HER2 breast cancer therapies: a review.

Authors:  Conleth G Murphy; Shanu Modi
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.